LOS ANGELES, CALIFORNIA – January 5, 2023 (GLOBE NEWSWIRE) – MetAlert, Inc. (OTC: MLRT), a pioneer in location-sensitive health monitoring devices and wearable technology products for remote patient monitoring, today issued its year-end shareholder letter.
Dear Shareholders and Stakeholders,
The management of MetAlert would like to thank you for supporting us. We highly value our shareholders and each of you help us fulfill our mission as a “For Profit with Purpose” company. As many of you know, our products positively impact our users and those people who care about them (family, loved ones, caregivers, neighbors, etc.). Your investment in MetAlert makes a difference.
We want to walk you through what has transpired over the past year, give you a little insight into the reasoning behind some of the recent actions that took place, and share our opinions about what may be impacting our stock price recently, especially considering the downturn in the stock market.
First, on the restructuring and rebranding, we waited patiently until we had substantially improved our balance sheet. Now, we are prepared to take the Company to the next level. Post-pandemic, we realized there was this tremendous opportunity in front of us, but our previous name, stock price and market cap did not properly reflect the Company’s vision, mission, and, most importantly, where it was heading. So, we changed our name, our ticker symbol, conducted a reverse split, and set our sights on the future. To successfully accomplish our objectives, these big changes were necessary. We needed a new, bolder name that articulated our mission as we work to deliver our customers with a broader offering of products and we seek to improve the value we drive for you, our valued shareholders. We are attracting new investors, partners, vendors, and larger customers to execute our growth strategy.
Metalert is a steadfast company with significant potential.
Let’s start at the beginning of 2022; we set out to enhance the capabilities of our patented flagship GPS SmartSoleR and we have since developed and launched SmartSole plusR. SmartSole plusR is a wearable hub for collecting health data in real-time wherever our users are, rather than only when they visit a doctor’s office. Our customers can avoid uncomfortable environments and possible exposure to ailments or delays in critical diagnosis. This expands MetAlert’s value proposition from a wandering device solution by the availability of daily health data.
For background, during the pandemic, we quickly recognized that a person’s overall health was key in terms of contracting Covid, its severity, and even life or death. We also observed that getting a checkup at a medical facility was sometimes perceived as a greater risk to someone’s health than underpinning health issues, revealing substantial and systemic issues with healthcare. This, along with some other converging factors, such as wide adoption of telehealth and related third-party payer approval, the ability for wireless networks to transmit large amounts of data in nanoseconds, and advancements in artificial intelligence, led us to make the decision to expand our tracking and monitoring platform. MetAlert provides a complete indoor/outdoor remote patient monitoring biometric health and wellness solution, with potential for insurance reimbursement and possibly, a long-term predictive A.I. big data play.